dallas semaglutide pancreatitis class action We have issued updated product information for healthcare professionals and patients regarding the small risk of severe acute in patients taking Glucagon-Like Peptide-1 receptor agonists or dual GLP-1/ glucose-dependent insulinotropic Ozempic Lawsuit: July 2026 Blindness

Absorption can be reduced by age, gut health, GI surgery, or medications, making direct delivery methods more reliable for restoring function

Thats why people often hear it spoken about in the same breath as GLP-1 medicines, even though technically its a broader, dual-action medicine

Among 17,604 participants with established cardiovascular disease and overweight or obesity but without diabetes, the primary event hazard ratio was 0.80 (95% CI 0.72-0.90) over a mean 39.8-month follow-up

She also lives very close to us

Understanding your data with Shotsy When you understand how your medication works, your tracking data tells a richer story